Variant report

Variant	esv2757696
Chromosome Location	chr19:41431935-41528667
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:855)
CpG islands
(count:793)
Chromatin interactive
region (count:25)
LncRNA
region (count:7)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:855 , 50 per page) page: 1 2 3 4 5 6 7 ... 18

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr19:41486058-41486085	HepG2	liver:	n/a	n/a
2	ARID3A	chr19:41506351-41506450	HepG2	liver:	n/a	n/a
3	ARID3A	chr19:41507311-41507499	K562	blood:	n/a	n/a
4	ATF1	chr19:41468671-41468771	K562	blood:	n/a	n/a
5	ATF1	chr19:41434897-41435097	K562	blood:	n/a	n/a
6	ATF3	chr19:41506069-41506786	HCT-116	colon:	n/a	n/a
7	ATF3	chr19:41506140-41506734	HCT-116	colon:	n/a	n/a
8	ATF3	chr19:41506267-41506508	K562	blood:	n/a	n/a
9	ATF3	chr19:41468329-41468885	A549	lung:	n/a	n/a
10	BACH1	chr19:41437946-41438301	H1-hESC	embryonic stem cell:	n/a	n/a
11	BACH1	chr19:41437956-41438260	K562	blood:	n/a	n/a
12	BACH1	chr19:41488176-41489166	H1-hESC	embryonic stem cell:	n/a	n/a
13	BCL3	chr19:41468223-41469050	A549	lung:	n/a	n/a
14	BCL3	chr19:41468291-41469001	A549	lung:	n/a	n/a
15	BHLHE40	chr19:41507420-41507421	K562	blood:	n/a	n/a
16	BRCA1	chr19:41465957-41466156	GM12878	blood:	n/a	n/a
17	CBX3	chr19:41482345-41482685	K562	blood:	n/a	n/a
18	CBX3	chr19:41460434-41460907	K562	blood:	n/a	n/a
19	CBX3	chr19:41505993-41506787	HCT-116	colon:	n/a	n/a
20	CBX3	chr19:41460404-41460899	K562	blood:	n/a	n/a
21	CCNT2	chr19:41434884-41435092	K562	blood:	n/a	n/a
22	CEBPB	chr19:41434755-41435152	K562	blood:	n/a	n/a
23	CEBPB	chr19:41506244-41506603	ECC-1	luminal epithelium:	n/a	chr19:41506435-41506446
24	CEBPB	chr19:41506884-41506987	IMR90	lung:	n/a	n/a
25	CEBPB	chr19:41488434-41488797	HepG2	liver:	n/a	chr19:41488609-41488620 chr19:41488607-41488620 chr19:41488609-41488618 chr19:41488607-41488618 chr19:41488607-41488620
26	CEBPB	chr19:41488408-41488845	MCF-7	breast:	n/a	chr19:41488609-41488620 chr19:41488607-41488620 chr19:41488609-41488618 chr19:41488607-41488618 chr19:41488607-41488620
27	CEBPB	chr19:41506256-41506628	Hela-S3	cervix:	n/a	chr19:41506435-41506446
28	CEBPB	chr19:41507152-41507489	K562	blood:	n/a	n/a
29	CEBPB	chr19:41468308-41469019	Hela-S3	cervix:	n/a	chr19:41468797-41468810
30	CEBPB	chr19:41488438-41488777	K562	blood:	n/a	chr19:41488609-41488620 chr19:41488607-41488620 chr19:41488609-41488618 chr19:41488607-41488618 chr19:41488607-41488620
31	CEBPB	chr19:41506284-41507442	A549	lung:	n/a	chr19:41506435-41506446
32	CEBPB	chr19:41488481-41488681	Hela-S3	cervix:	n/a	chr19:41488609-41488620 chr19:41488607-41488620 chr19:41488609-41488618 chr19:41488607-41488618 chr19:41488607-41488620
33	CEBPB	chr19:41438982-41439268	H1-hESC	embryonic stem cell:	n/a	n/a
34	CEBPB	chr19:41446714-41446729	A549	lung:	n/a	n/a
35	CEBPB	chr19:41434742-41435118	K562	blood:	n/a	n/a
36	CEBPB	chr19:41506263-41507465	K562	blood:	n/a	chr19:41506435-41506446
37	CEBPB	chr19:41488441-41488804	IMR90	lung:	n/a	chr19:41488609-41488620 chr19:41488607-41488620 chr19:41488609-41488618 chr19:41488607-41488618 chr19:41488607-41488620
38	CEBPB	chr19:41488522-41488635	HepG2	liver:	n/a	chr19:41488609-41488620 chr19:41488607-41488620 chr19:41488609-41488618 chr19:41488607-41488618 chr19:41488607-41488620
39	CEBPB	chr19:41488440-41489019	H1-hESC	embryonic stem cell:	n/a	chr19:41488609-41488620 chr19:41488607-41488620 chr19:41488609-41488618 chr19:41488607-41488618 chr19:41488607-41488620
40	CEBPB	chr19:41506268-41506934	HepG2	liver:	n/a	chr19:41506435-41506446
41	CEBPB	chr19:41505976-41507518	HCT-116	colon:	n/a	chr19:41506435-41506446
42	CEBPB	chr19:41468301-41468559	HepG2	liver:	n/a	n/a
43	CEBPB	chr19:41506208-41506618	A549	lung:	n/a	chr19:41506435-41506446
44	CEBPB	chr19:41468165-41469078	A549	lung:	n/a	chr19:41468797-41468810
45	CEBPB	chr19:41506068-41507138	HCT-116	colon:	n/a	chr19:41506435-41506446
46	CEBPB	chr19:41434826-41435086	K562	blood:	n/a	n/a
47	CEBPB	chr19:41486262-41486477	HepG2	liver:	n/a	n/a
48	CEBPB	chr19:41488422-41488791	A549	lung:	n/a	chr19:41488609-41488620 chr19:41488607-41488620 chr19:41488609-41488618 chr19:41488607-41488618 chr19:41488607-41488620
49	CEBPB	chr19:41506189-41507135	A549	lung:	n/a	chr19:41506435-41506446
50	CEBPB	chr19:41438733-41439296	A549	lung:	n/a	n/a

(count:793 , 50 per page) page: 1 2 3 4 5 6 7 ... 16

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr19:41510272-41510322	HIPEpiC	eye:	n/a
2	chr19:41527828-41527878	NH-A	brain:	n/a
3	chr19:41524298-41524348	AG04449	skin:	fetal
4	chr19:41510098-41510148	ovcar-3	ovarian:	n/a
5	chr19:41510098-41510148	HRCEpiC	kidney:	n/a
6	chr19:41510098-41510148	HNPCEpiC	eye:	n/a
7	chr19:41510272-41510322	MCF-7	breast:	n/a
8	chr19:41495942-41495992	HUVEC	blood vessel:	n/a
9	chr19:41524298-41524348	AG04450	lung:	fetal
10	chr19:41496043-41496093	RPTEC	kidney:	n/a
11	chr19:41497222-41497272	GM12892	blood:	n/a
12	chr19:41527828-41527878	HPAEpiC	pulmonary alveolar:	n/a
13	chr19:41510059-41510109	U87	brain:	n/a
14	chr19:41527828-41527878	HEK293	kidney:	embryo
15	chr19:41527828-41527878	HRPEpiC	eye:	n/a
16	chr19:41510098-41510148	ProgFib	skin:	n/a
17	chr19:41495942-41495992	HCPEpiC	choroid plexus:	n/a
18	chr19:41510026-41510076	HNPCEpiC	eye:	n/a
19	chr19:41527828-41527878	ECC-1	luminal epithelium:	n/a
20	chr19:41496043-41496093	AoSMC	blood vessel:	n/a
21	chr19:41510037-41510087	MCF-7	breast:	n/a
22	chr19:41510059-41510109	HRE	kidney:	n/a
23	chr19:41527828-41527878	NB4	blood:	n/a
24	chr19:41495942-41495992	AG09319	gingival:	n/a
25	chr19:41496749-41496799	NT2-D1	testis:	n/a
26	chr19:41510059-41510109	HIPEpiC	eye:	n/a
27	chr19:41527828-41527878	K562	blood:	n/a
28	chr19:41495942-41495992	A549	lung:	n/a
29	chr19:41495942-41495992	HIPEpiC	eye:	n/a
30	chr19:41510272-41510322	MCF10A-Er-Src	breast:	n/a
31	chr19:41510285-41510335	AG10803	skin:	n/a
32	chr19:41510272-41510322	NH-A	brain:	n/a
33	chr19:41496749-41496799	H1-hESC	embryonic stem cell:	embryo
34	chr19:41510098-41510148	HUVEC	blood vessel:	n/a
35	chr19:41510243-41510293	SK-N-SH_RA	brain:	n/a
36	chr19:41510272-41510322	GM06990	blood:	n/a
37	chr19:41495942-41495992	HEK293	kidney:	embryo
38	chr19:41510285-41510335	ProgFib	skin:	n/a
39	chr19:41496749-41496799	HAEpiC	amniotic membrane:	n/a
40	chr19:41510272-41510322	Caco-2	colon:	n/a
41	chr19:41510272-41510322	HCPEpiC	choroid plexus:	n/a
42	chr19:41524298-41524348	GM12878	blood:	n/a
43	chr19:41497222-41497272	HCPEpiC	choroid plexus:	n/a
44	chr19:41510098-41510148	IMR90	lung:	fetal
45	chr19:41495942-41495992	T-47D	breast:	n/a
46	chr19:41510037-41510087	CMK	blood:	n/a
47	chr19:41496043-41496093	SK-N-SH	brain:	n/a
48	chr19:41496043-41496093	HMEC	breast:	n/a
49	chr19:41497222-41497272	ECC-1	luminal epithelium:	n/a
50	chr19:41497222-41497272	SK-N-SH	brain:	n/a

(count:25 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr19:41463496..41465246-chr19:41466230..41468956,2	K562	blood:
2	chr19:41444451..41445965-chr19:41446160..41448128,2	MCF-7	breast:
3	chr19:41433604..41436108-chr19:41440713..41443622,2	MCF-7	breast:
4	chr19:41436490..41439337-chr19:41447432..41449781,2	MCF-7	breast:
5	chr19:41436490..41439337-chr19:41447432..41449781,2	MCF-7	breast:
6	chr19:41463243..41465087-chr19:41467190..41469905,2	K562	blood:
7	chr19:41433604..41436108-chr19:41440713..41443622,2	MCF-7	breast:
8	chr19:41438993..41440711-chr19:41442295..41445002,2	MCF-7	breast:
9	chr19:41455358..41456878-chr19:41467418..41469286,2	K562	blood:
10	chr19:41400931..41403268-chr19:41432541..41435329,2	K562	blood:
11	chr19:41480596..41481177-chr19:41649752..41650983,4	K562	blood:
12	chr19:41455358..41456878-chr19:41467418..41469286,2	K562	blood:
13	chr19:41463243..41465087-chr19:41467190..41469905,2	K562	blood:
14	chr19:41303781..41306051-chr19:41433024..41435492,2	MCF-7	breast:
15	chr19:41458951..41460963-chr19:41463374..41465958,2	K562	blood:
16	chr19:41435849..41437489-chr19:41440022..41442246,2	MCF-7	breast:
17	chr19:41480412..41481100-chr19:41650028..41650578,2	MCF-7	breast:
18	chr10:94639799..94640373-chr19:41475219..41475719,2	K562	blood:
19	chr19:41438993..41440711-chr19:41442295..41445002,2	MCF-7	breast:
20	chr19:41429883..41432599-chr19:41435321..41438137,2	MCF-7	breast:
21	chr19:41463496..41465246-chr19:41466230..41468956,2	K562	blood:
22	chr19:41435849..41437489-chr19:41440022..41442246,2	MCF-7	breast:
23	chr19:41458951..41460963-chr19:41463374..41465958,2	K562	blood:
24	chr19:41489930..41492049-chr19:41494201..41495851,2	K562	blood:
25	chr19:41489930..41492049-chr19:41494201..41495851,2	K562	blood:

(count:7 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-CYP2B6-1	chr19:41493956-41494534	l_1687_chr19:41492503-41503928_testes
2	lnc-CYP2B6-2	chr19:41452252-41452450	ENSG00000269353.1
3	lnc-CYP2B6-1	chr19:41503762-41503928	l_1687_chr19:41492503-41503928_testes
4	lnc-CYP2B6-2	chr19:41453006-41453355	ENSG00000269353.1
5	lnc-CYP2B6-1	chr19:41495264-41495408	l_1687_chr19:41492503-41503928_testes
6	lnc-CYP2B6-1	chr19:41492504-41492600	l_1687_chr19:41492503-41503928_testes
7	lnc-CYP2B6-1	chr19:41493177-41493736	l_1687_chr19:41492503-41503928_testes

No data

Variant related genes	Relation type
CYP2B6	TF binding region
ENSG00000269353	TF binding region
CYP2B7P	TF binding region
CYP2B6	CpG island
ENSG00000269353	CpG island
CYP2B7P	CpG island
ENSG00000256612	chromatin interactions
ENSG00000269858	chromatin interactions

Extended variants
information (count: 4427 )
Associated
traits (count: 65 )

Variant overlapped rSNPs/rCNVs (count:4427 , 50 per page) page: 1 2 3 4 5 6 7 ... 89

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs3844443	chr19:41431935-41431936	Weak transcription Flanking Active TSS Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
2	rs186855287	chr19:41431943-41431944	Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
3	rs191242912	chr19:41431980-41431981	Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
4	rs533249781	chr19:41432028-41432029	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
5	rs544255389	chr19:41432036-41432037	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
6	rs562436695	chr19:41432099-41432100	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
7	rs373800618	chr19:41432111-41432112	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
8	rs140308067	chr19:41432151-41432152	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
9	rs546399097	chr19:41432197-41432198	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
10	rs182524698	chr19:41432266-41432267	Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
11	rs528765299	chr19:41432269-41432270	Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
12	rs143984250	chr19:41432273-41432274	Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
13	rs544690523	chr19:41432284-41432285	Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
14	rs566514675	chr19:41432290-41432291	Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
15	rs575796637	chr19:41432291-41432292	Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
16	rs560485649	chr19:41432293-41432294	Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
17	rs145365541	chr19:41432307-41432308	Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
18	rs111870127	chr19:41432341-41432342	Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
19	rs568399904	chr19:41432397-41432398	Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
20	rs190038074	chr19:41432402-41432403	Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
21	rs550999605	chr19:41432450-41432451	Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
22	rs182265340	chr19:41432485-41432486	Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
23	rs530539997	chr19:41432496-41432497	Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
24	rs117769825	chr19:41432516-41432517	Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
25	rs188914601	chr19:41432526-41432527	Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
26	rs370482536	chr19:41432545-41432546	Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
27	rs548986248	chr19:41432547-41432548	Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
28	rs193234837	chr19:41432548-41432549	Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
29	rs112795140	chr19:41432574-41432575	Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
30	rs568862433	chr19:41432593-41432594	Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
31	rs533789734	chr19:41432598-41432599	Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
32	rs555384382	chr19:41432627-41432628	Enhancers Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
33	rs137870022	chr19:41432628-41432629	Enhancers Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
34	rs185267161	chr19:41432635-41432636	Enhancers Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
35	rs556153139	chr19:41432690-41432691	Enhancers Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
36	rs577798604	chr19:41432693-41432694	Enhancers Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
37	rs545144871	chr19:41432712-41432713	Enhancers Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
38	rs73931398	chr19:41432744-41432745	Enhancers Weak transcription Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
39	rs547168400	chr19:41432754-41432755	Enhancers Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
40	rs142358195	chr19:41432756-41432757	Enhancers Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
41	rs540859863	chr19:41432784-41432785	Enhancers Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
42	rs200268253	chr19:41432791-41432792	Enhancers Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
43	rs145854802	chr19:41432951-41432952	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
44	rs529619661	chr19:41432972-41432973	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
45	rs188534483	chr19:41433033-41433034	Weak transcription Enhancers Flanking Active TSS Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
46	rs373892010	chr19:41433056-41433057	Weak transcription Enhancers Flanking Active TSS Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
47	rs138348261	chr19:41433089-41433090	Weak transcription Enhancers Flanking Active TSS Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
48	rs3865459	chr19:41433113-41433114	Weak transcription Enhancers Flanking Active TSS Active TSS	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
49	rs149613261	chr19:41433151-41433152	Weak transcription Enhancers Flanking Active TSS Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
50	rs557414136	chr19:41433161-41433162	Weak transcription Enhancers Flanking Active TSS Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:65)

Disease	PMID	Source
Myelodysplastic syndrome	17634407	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Chordoma	21602918	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Cancer	21637783	CNVD
Retinoblastoma	21504564	CNVD
Medulloblastoma	21979893	CNVD
Ovarian cancer	21720365	CNVD
Cancer	20164919	CNVD
Thoracic aortic aneurysm	21092924	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Prostate cancer	18632612	CNVD
Autism	22495311	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Ductal carcinoma	22052326	CNVD
Congenital nephrotic syndrome	18421352	CNVD
Astrocytoma	17934521	CNVD
Leukemia	17361228	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Breast cancer	21858162	CNVD
Breast cancer	17603634	CNVD
Glioma	21971842	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Endometrial cancer	22040021	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Oligodendroglial tumors	17285580	CNVD
renal disease	20603712	CNVD
Salivary gland adenoid cystic carcinoma	17545515	CNVD
Ovarian cancer	22174824	CNVD
Breast cancer	16608533	CNVD
Neuroblastoma	18923191	CNVD
Breast cancer	21364760	CNVD
Invasive pancreatic ductal carcinoma	18765526	CNVD
Rhabdomyosarcoma	16790082	CNVD
Chordoma	18071362	CNVD
Urothelial carcinoma	21177765	CNVD
small cell lung cancer	20016488	CNVD
Wilms tumour	21544195	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Ovarian neoplasms	16753589	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Metanephric adenoma	20802469	CNVD
Acute myeloid leukemia	16864856	CNVD
Bladder cancer	21909424	CNVD
Medulloblastoma	16783165	CNVD
Gastric cancer	18160780	CNVD
Hepatocellular carcinoma	16750200	CNVD
Basal cell lymphoma	19029149	CNVD
Breast cancer	20409316	CNVD
Diffuse large b-cell lymphoma	19029149	CNVD
Multiple myeloma	16616336	CNVD
Renal cell carcinoma	18765545	CNVD
Acute myeloid leukemia	20729466	CNVD
Lung cancer	18438408	CNVD
Genital abnormality	22378287	CNVD
Hypospadia	22378287	CNVD
Ovarian clear cell carcinoma	19293255	CNVD
Astrocytoma	22246337	CNVD
Non-syndromic sensorineural hearing loss	17431168	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:365 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr19:41429000-41434200	Weak transcription	K562	blood
2	chr19:41429200-41434600	Weak transcription	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
3	chr19:41430200-41433200	Active TSS	Lung	lung
4	chr19:41430400-41432800	Active TSS	Fetal Intestine Small	intestine
5	chr19:41430600-41432600	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
6	chr19:41430800-41432800	Active TSS	Fetal Intestine Large	intestine
7	chr19:41431600-41432000	Flanking Active TSS	Liver	Liver
8	chr19:41432000-41432200	Enhancers	Liver	Liver
9	chr19:41432200-41447600	Weak transcription	Liver	Liver
10	chr19:41432400-41432600	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
11	chr19:41432600-41433000	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
12	chr19:41432600-41434600	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
13	chr19:41432800-41433000	Flanking Active TSS	Fetal Intestine Small	intestine
14	chr19:41432800-41433200	Flanking Active TSS	Fetal Intestine Large	intestine
15	chr19:41433000-41435200	Enhancers	Fetal Intestine Small	intestine
16	chr19:41433000-41437800	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
17	chr19:41433200-41434400	Enhancers	Fetal Intestine Large	intestine
18	chr19:41434200-41434400	Bivalent Enhancer	A549	lung
19	chr19:41434200-41436000	Enhancers	K562	blood
20	chr19:41434400-41434800	Flanking Active TSS	Fetal Intestine Large	intestine
21	chr19:41434600-41435000	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
22	chr19:41434600-41435000	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
23	chr19:41434800-41436200	Enhancers	Fetal Intestine Large	intestine
24	chr19:41435000-41435600	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
25	chr19:41435200-41435400	Flanking Active TSS	Fetal Intestine Small	intestine
26	chr19:41435400-41436200	Enhancers	Fetal Intestine Small	intestine
27	chr19:41436000-41437600	Weak transcription	K562	blood
28	chr19:41436200-41436600	Weak transcription	Fetal Intestine Small	intestine
29	chr19:41436200-41437800	Weak transcription	Fetal Intestine Large	intestine
30	chr19:41436600-41437000	Strong transcription	Fetal Intestine Small	intestine
31	chr19:41437000-41437800	Weak transcription	Fetal Intestine Small	intestine
32	chr19:41437600-41438000	Enhancers	HUES6 Cell Line	embryonic stem cell
33	chr19:41437600-41439800	Enhancers	K562	blood
34	chr19:41437800-41438000	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
35	chr19:41437800-41438000	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
36	chr19:41437800-41438200	Genic enhancers	Fetal Intestine Small	intestine
37	chr19:41437800-41438600	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
38	chr19:41437800-41438800	Enhancers	Fetal Intestine Large	intestine
39	chr19:41438000-41439400	Bivalent Enhancer	A549	lung
40	chr19:41438200-41438400	Enhancers	ES-I3 Cell Line	embryonic stem cell
41	chr19:41438200-41438600	Enhancers	ES-WA7 Cell Line	embryonic stem cell
42	chr19:41438200-41442000	Weak transcription	Fetal Intestine Small	intestine
43	chr19:41438400-41438800	Enhancers	Primary neutrophils fromperipheralblood	blood
44	chr19:41438400-41439000	Weak transcription	ES-I3 Cell Line	embryonic stem cell
45	chr19:41438400-41439000	Enhancers	Placenta	Placenta
46	chr19:41438600-41439000	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
47	chr19:41438600-41439600	Weak transcription	ES-WA7 Cell Line	embryonic stem cell
48	chr19:41438800-41444000	Weak transcription	Fetal Intestine Large	intestine
49	chr19:41439000-41439200	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
50	chr19:41439000-41439200	Enhancers	Stomach Mucosa	stomach

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links